AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.990
-0.120 (-3.86%)
Sep 6, 2024, 4:00 PM EDT - Market closed
AC Immune Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AC Immune stock have an average target of 12, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 301.34% from the current stock price of 2.99.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 31, 2024.
Analyst Ratings
The average analyst rating for AC Immune stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +167.56% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +435.12% | Mar 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +435.12% | Nov 13, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +435.12% | Aug 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +435.12% | Jun 28, 2023 |
Financial Forecast
Revenue This Year
4.92M
from 14.80M
Decreased by -66.79%
Revenue Next Year
58.06M
from 4.92M
Increased by 1,081.36%
EPS This Year
-0.81
from -0.64
EPS Next Year
-0.41
from -0.81
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.6M | 147.8M | 178.8M | ||
| Avg | 4.9M | 58.1M | 103.0M | ||
| Low | 686,000 | n/a | 31.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -14.9% | 2,907.5% | 207.9% | ||
| Avg | -66.8% | 1,081.4% | 77.4% | ||
| Low | -95.4% | - | -46.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.79 | 0.29 | 0.55 | ||
| Avg | -0.81 | -0.41 | -0.29 | ||
| Low | -0.83 | -0.91 | -0.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.